Dupixent® / Sanofi Genzyme Head on Incredible Success of "Once-in-a-Career" Product
Sanofi’s inflammation drug Dupixent® is driving a substantial percentage of the firm’s sales in 2020, reaching USD 1.92 billion in the first half of the year, with a reported growth…